Core Viewpoint - WORK Medical Technology Group LTD has entered into a strategic cooperation agreement with the Hong Kong Web3.0 Standardization Association to promote innovation in the Real-world Asset (RWA) sector through resource sharing and complementary strengths [1][4]. Group 1: Strategic Cooperation Agreement - The agreement focuses on collaboration in blockchain solutions, including asset tokenization, equity investment, and RWA technology development [4][5]. - WORK Medical will leverage its capital resources and expertise in medical device manufacturing alongside the Association's resources to advance asset tokenization [4]. - The partnership aims to integrate industrial and financial resources for co-investments to accelerate RWA market expansion [4]. Group 2: Association's Role and Objectives - The Hong Kong Web3.0 Standardization Association is dedicated to supporting the growth of Hong Kong's Web3.0 ecosystem through standardization and research [6]. - The Association's initiatives include promoting technological advancement, establishing standards, and enhancing public awareness of Web3.0 [6]. - The Association launched an RWA registration platform in August 2025 to further its mission [6]. Group 3: Company Profile - WORK Medical develops and manufactures Class I and II medical devices, with a diverse product portfolio of 21 products sold in 34 regions in China and over 30 countries worldwide [8]. - The company has received quality-related manufacturing designations and has registered 17 products with the U.S. FDA for market entry in the U.S. [8].

Core Viewpoint - WORK Medical Technology Group LTD has signed a strategic cooperation agreement with Xin Rui Hospital to develop AI-driven medical products, aiming to enhance the digital healthcare ecosystem in China [1][2][4]. Group 1: Agreement Details - The agreement involves Work Hangzhou supporting Xin Rui Hospital in advancing hospital informatization and the application of AI-powered medical products [2]. - The collaboration aims to integrate AI technology with various medical resources at Xin Rui Hospital, including text, imaging, and laboratory data, to create a digital knowledge base for intelligent healthcare [2]. - The partnership is expected to enhance the development and clinical application of AI models across multiple healthcare scenarios, focusing on data governance, model training, and translating research into clinical practice [2]. Group 2: Company Background - WORK Medical Technology Group LTD, through its subsidiary Work (Hangzhou) Medical Treatment Equipment Co., Ltd., develops and manufactures Class I and II medical devices, with a diverse product portfolio of 21 items [5]. - The company has products sold in 34 provincial-level regions in China and has registered 17 products with the U.S. Food and Drug Administration, allowing entry into the U.S. market [5]. Group 3: Leadership Perspective - The CEO of WORK Medical expressed enthusiasm about the partnership, highlighting the goal of establishing a model for hospital digitalization and intelligent healthcare applications [4]. - The collaboration is anticipated to accelerate AI transformation in domestic hospitals and broaden the adoption of technology solutions [4].

Core Viewpoint - Wok Medical (WOK) experienced a stock price increase of 4.8% on August 20, 2023, closing at $0.83 per share, with a total market capitalization of $46.92 million [1] Financial Performance - As of September 30, 2024, Wok Medical reported total revenue of $11.5064 million, representing a year-over-year decrease of 15.18% [1] - The company's net profit attributable to shareholders was -$3.4923 million, reflecting a significant year-over-year decline of 3217.31% [1] Company Overview - Wok Medical Technology Group Co., Ltd. is a foreign holding company registered in the Cayman Islands, primarily operating through its domestic subsidiary, Hangzhou Shanyou Medical Equipment Co., Ltd. [1] - The subsidiary, established in April 2002, specializes in the production of medical consumables, including anesthesia, respiratory, emergency, ICU, interventional products, and masks, utilizing advanced plastic injection, extrusion molding, and packaging sealing equipment [1]

Core Viewpoint - Wok Medical (WOK) experienced a stock price increase of 3.72% on August 18, reaching $0.8 per share, with a total market capitalization of $45.23 million [1] Financial Performance - As of September 30, 2024, Wok Medical reported total revenue of $11.51 million, representing a year-over-year decrease of 15.18% [1] - The company recorded a net profit attributable to shareholders of -$3.49 million, which is a significant decline of 3217.31% year-over-year [1] Company Overview - Wok Medical Technology Group Co., Ltd. is a foreign holding company registered in the Cayman Islands, primarily operating through its domestic subsidiary, Hangzhou Shanyou Medical Equipment Co., Ltd. [1] - The subsidiary, established in April 2002, specializes in the production of medical consumables such as anesthesia, respiratory, emergency, ICU, interventional products, and masks, utilizing advanced plastic injection, extrusion molding, and packaging sealing equipment [1]

Core Viewpoint - Wok Medical (WOK) experienced a 2.5% increase in stock price, reaching $0.8 per share, with a total market capitalization of $45.23 million as of August 14 [1] Financial Performance - For the fiscal year ending September 30, 2024, Wok Medical reported total revenue of $11.51 million, reflecting a year-over-year decrease of 15.18% [1] - The company recorded a net profit attributable to shareholders of -$3.49 million, which represents a significant year-over-year decline of 3217.31% [1] Company Overview - Wok Medical Technology Group Co., Ltd. is a Cayman Islands-registered holding company that primarily operates through its domestic subsidiary, Hangzhou Shanyou Medical Equipment Co., Ltd. [1] - The subsidiary, established in April 2002, specializes in the production of medical consumables, including anesthesia, respiratory, emergency, ICU, interventional products, and masks, utilizing advanced plastic injection, extrusion molding, and packaging sealing equipment [1]

Core Viewpoint - Wok Medical (WOK) experienced a stock price increase of 3.24% on August 6, reaching $0.793 per share, with a total market capitalization of $44.83 million [1] Financial Performance - As of September 30, 2024, Wok Medical reported total revenue of $11.51 million, representing a year-over-year decrease of 15.18% [1] - The company recorded a net profit attributable to shareholders of -$3.49 million, which is a significant decline of 3217.31% year-over-year [1] Company Overview - Wok Medical Technology Group Co., Ltd. is a foreign holding company registered in the Cayman Islands, primarily operating through its domestic subsidiary, Hangzhou Shanyou Medical Equipment Co., Ltd. [1] - The subsidiary, established in April 2002, specializes in the production of medical consumables such as anesthesia, respiratory, emergency, ICU, interventional products, and masks, utilizing advanced equipment for plastic injection, extrusion molding, and packaging sealing [1]

Core Viewpoint - Wok Medical (WOK) experienced a significant stock price increase of 10.66% on August 5, reaching $0.85 per share, with a total market capitalization of $48.05 million [1] Financial Performance - As of September 30, 2024, Wok Medical reported total revenue of $11.5064 million, reflecting a year-over-year decrease of 15.18% [1] - The company recorded a net profit attributable to the parent of -$3.4923 million, which represents a staggering year-over-year decline of 3217.31% [1] Company Overview - Wok Medical Technology Group Co., Ltd. is a foreign holding company registered in the Cayman Islands, primarily operating through its domestic subsidiary, Hangzhou Shanyou Medical Equipment Co., Ltd. [1] - The subsidiary, established in April 2002, specializes in the production of medical consumables such as anesthesia, respiratory, emergency, ICU, interventional products, and masks, utilizing advanced equipment for plastic injection, extrusion molding, and packaging sealing [1]

Core Viewpoint - Wok Medical (WOK) experienced a stock price increase of 4.29% on July 29, reaching $0.85 per share, with a total market capitalization of $48.05 million [1] Financial Performance - As of September 30, 2024, Wok Medical reported total revenue of $11.5064 million, representing a year-over-year decrease of 15.18% [1] - The company recorded a net profit attributable to shareholders of -$3.4923 million, which is a significant decline of 3217.31% year-over-year [1] Company Overview - Wok Medical Technology Group Co., Ltd. is a foreign holding company registered in the Cayman Islands, primarily operating through its domestic subsidiary, Hangzhou Shanyou Medical Equipment Co., Ltd. [1] - The subsidiary, established in April 2002, specializes in the production of medical consumables such as anesthesia, respiratory, emergency, ICU, interventional products, and masks, utilizing advanced equipment for plastic injection, extrusion molding, and packaging sealing [1]

Company Overview - WORK Medical Technology Group LTD is a supplier of medical devices in China, operating through its subsidiary Work (Hangzhou) Medical Treatment Equipment Co., Ltd. and other subsidiaries [8] - The company develops and manufactures Class I and II medical devices, including customized and multifunctional masks, and sells disposable medical devices [8] - WORK Medical Technology has a diverse product portfolio comprising 21 products, with sales in 34 provincial-level administrative regions in China and exports to over 30 countries [8] - The company has received multiple quality-related manufacturing designations and has registered 17 products with the U.S. Food and Drug Administration, allowing entry into the U.S. market [8] Offering Details - The company closed a registered offering, selling an aggregate of 10,000,000 ordinary units at an offering price of $0.50 per unit, resulting in gross proceeds of approximately $5 million [2][4] - Each ordinary unit consists of one Class A ordinary share, one Series A warrant, and one Series B warrant, both with an exercise price of $1.00 [3] - The Series A warrants expire in 12 months, while the Series B warrants expire in 3 months, and both are immediately exercisable upon issuance [3] Underwriting and Regulatory Compliance - Univest Securities, LLC acted as the sole book-running manager for the offering [4] - The offering was made pursuant to a registration statement on Form F-1, which was declared effective by the U.S. Securities and Exchange Commission [5]

Core Viewpoint - WORK Medical Technology Group LTD has successfully closed a registered offering of 10,000,000 ordinary units at a price of $0.50 per unit, raising a total of $5.0 million before expenses [1][3]. Summary by Sections Offering Details - Each ordinary unit consists of one Class A ordinary share, one Series A warrant, and one Series B warrant, both with an exercise price of $1.00 [2]. - The Series A warrants expire in 12 months, while the Series B warrants expire in 3 months [2]. - The offering was conducted on a firm commitment basis, with Univest Securities, LLC serving as the sole book-running manager [4]. Use of Proceeds - Proceeds from the offering will be allocated for upgrading production equipment, investing in research and development, hiring experienced employees for compliance improvements, and general corporate purposes [3]. Company Overview - WORK Medical Technology Group LTD is a supplier of medical devices in China, developing and manufacturing Class I and II medical devices [6]. - The company has a diverse product portfolio of 21 products, including customized masks and medical consumables, sold in 34 regions in China and over 30 countries globally [6]. - The company has received multiple quality-related manufacturing designations and has registered 17 products with the U.S. FDA for market entry in the U.S. [6].